These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9730075)

  • 1. Prevalence variations in psychotropic treatment of children.
    Zito JM; Safer DJ; Riddle MA; Johnson RE; Speedie SM; Fox M
    J Child Adolesc Psychopharmacol; 1998; 8(2):99-105. PubMed ID: 9730075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the prescribing of psychotropic medications to preschoolers.
    Zito JM; Safer DJ; dosReis S; Gardner JF; Boles M; Lynch F
    JAMA; 2000 Feb; 283(8):1025-30. PubMed ID: 10697062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate patterns among Medicaid youths.
    Zito JM; Safer DJ; dosReis S; Magder LS; Riddle MA
    Psychopharmacol Bull; 1997; 33(1):143-7. PubMed ID: 9133766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the use of psychotropic medications among adolescents, 1994 to 2001.
    Thomas CP; Conrad P; Casler R; Goodman E
    Psychiatr Serv; 2006 Jan; 57(1):63-9. PubMed ID: 16399964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data.
    Acquaviva E; Legleye S; Auleley GR; Deligne J; Carel D; Falissard B B
    BMC Psychiatry; 2009 Nov; 9():72. PubMed ID: 19919701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperactivity and prescription of Ritalin in the canton of Vaud (Switzerland), 2002].
    Huissoud T; Jeannin A; Dubois-Arber F
    Rev Epidemiol Sante Publique; 2007 Oct; 55(5):357-63. PubMed ID: 17889474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
    Sabelli HC; Fawcett J; Javaid JI; Bagri S
    Am J Psychiatry; 1983 Feb; 140(2):212-4. PubMed ID: 6849437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small geographic area variations in prescription drug use.
    Weinstein SJ; House SA; Chang CH; Wasserman JR; Goodman DC; Morden NE
    Pediatrics; 2014 Sep; 134(3):563-70. PubMed ID: 25113303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age on the profile of psychotropic users: results from the 2010 National Ambulatory Medical Care Survey.
    Maust DT; Oslin DW; Marcus SC
    J Am Geriatr Soc; 2014 Feb; 62(2):358-64. PubMed ID: 24417590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Millichap JG
    Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851
    [No Abstract]   [Full Text] [Related]  

  • 14. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
    Khanna R; Jariwala K; West-Strum D
    J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
    Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
    Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential clinical use for methylphenidate with tricyclic antidepressants.
    Wharton RN; Perel JM; Dayton PG; Malitz S
    Am J Psychiatry; 1971 Jun; 127(12):1619-25. PubMed ID: 4998422
    [No Abstract]   [Full Text] [Related]  

  • 20. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.
    Moreno C; Laje G; Blanco C; Jiang H; Schmidt AB; Olfson M
    Arch Gen Psychiatry; 2007 Sep; 64(9):1032-9. PubMed ID: 17768268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.